Westbourne Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.64M Buy
3,869
+272
+8% +$278K 1.89% 11
2026
Q1
$3.31M Sell
3,597
-5
-0.1% -$5.07K 1.57% 19
2025
Q4
$3.87M Sell
3,602
-72
-2% -$68.8K 1.8% 14
2025
Q3
$3.17M Buy
3,674
+1,519
+70% +$1.13M 1.52% 20
2025
Q2
$1.68M Sell
2,155
-685
-24% -$532K 0.9% 38
2025
Q1
$2.35M Sell
2,840
-625
-18% -$520K 1.42% 17
2024
Q4
$2.67M Buy
+3,465
New +$2.87M 1.58% 15

Other funds holding LLY

Westbourne Investments's LLY Position: Q2 2026 in Review

Westbourne Investments increased its Eli Lilly (LLY) stake by 7.6% in Q2 2026, buying an estimated $278K and bringing the position to 3,869 shares worth $4.64M. The position accounts for 1.89% of the portfolio, ranked #11.

Westbourne Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Westbourne Investments held 3,869 shares of Eli Lilly worth $4.64M as of Q2 2026.
  • Westbourne Investments bought 272 Eli Lilly shares in Q2 2026, an estimated $278K.
  • Eli Lilly made up 1.89% of Westbourne Investments's portfolio in Q2 2026, its #11 holding.
  • Westbourne Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.